• Latest Posts

Advancing cancer care with 3D genomics

Sysnav and Roche partner on movement tracking technology

CytoReason expands deal with Sanofi to look at IBD

Netherlands Cancer Institute to use Proscia platform

Vésale Bioscience receives €1.8M grant for AMR phage project

2023: A pivotal time for medicine as it enters a new ‘personalized’ era

In Depth 5 Jan 2023

Navignostics maps tumor proteomes to improve precision oncology

Prenetics acquires ACT Genomics

OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023

Entact Bio launches with $81M to develop precision medicines

FogPharma raises $178M to target cancer

NW Bio reports positive top-line results from phase 3 glioblastoma trial